Type to search

Avacta Selects Second pre|CISION™ Pro-drug Candidate for Development | Pharmtech Focus
Sciwind Biosciences Announces Initiation of Patient Dosing in Phase 2b Clinical Trial Evaluating XW003, its Lead GLP-1 Drug Candidate, for the Treatment of Obesity | Pharmtech Focus
New Study: Decentralized Clinical Trials Can Achieve Net Financial Benefits of 5X to 14X, Due to Reduced Trial Timelines and Other Factors | Pharmtech Focus